Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Alaunos Therapeutics, Inc. (TCRT) had Free Cash Flow per Share of $-0.53 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-1.01M |
|
-- |
|
-- |
|
$1.01M |
|
$-1.01M |
|
$0.01M |
|
$-1.01M |
|
$-1.01M |
|
$-1.01M |
|
$-1.01M |
|
$-1.01M |
|
$-1.01M |
|
$-1.01M |
|
$-1.00M |
|
1.95M |
|
1.95M |
|
$-0.59 |
|
$-0.59 |
|
| Balance Sheet Financials | |
$0.97M |
|
$0.08M |
|
$0.91M |
|
$1.88M |
|
$0.59M |
|
-- |
|
-- |
|
$0.59M |
|
$1.29M |
|
$1.29M |
|
$1.29M |
|
2.38M |
|
| Cash Flow Statement Financials | |
$-1.03M |
|
$0.00M |
|
$0.00M |
|
$1.39M |
|
$0.35M |
|
$-1.03M |
|
$0.06M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.63 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.03M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-78.10% |
|
-78.11% |
|
-53.43% |
|
-78.11% |
|
$0.54 |
|
|
Free Cash Flow per Share |
$-0.53 |
$-0.53 |
|